-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F5Dh6LkknxIAt8nrdtYOUisBmeMQHGAsvctxLo4ss2W6WQZm7vDKc+tfGrt3oIe5 gIg/O9s/eLpqgrodiNPLdA== 0001209191-05-038492.txt : 20050725 0001209191-05-038492.hdr.sgml : 20050725 20050725184056 ACCESSION NUMBER: 0001209191-05-038492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050725 FILED AS OF DATE: 20050725 DATE AS OF CHANGE: 20050725 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DELEAGE JEAN CENTRAL INDEX KEY: 0001198323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29889 FILM NUMBER: 05972437 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER SUITE 450 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-07-25 0 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001198323 DELEAGE JEAN ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 1 0 0 0 Common Stock 2005-07-25 4 S 0 6173 20.3672 D 481317 I See footnote Common Stock 2005-07-25 4 S 0 227 20.3672 D 17707 I See footnote Not applicable Jean Deleage, Director, is a managing director of Alta BioPharma Management II, LLC (which is the General Partner ("GP") of Alta BioPharma Partners II, L.P.("ABPII")) & a manager of Alta Embarcadero BioPharma Partners II, LLC ("AEBPII"). Alta Partners II, Inc. provides investment advisory services to several venture capital funds including ABPII & AEBPII. The respective GP & managers exercise sole voting & investment powers over the shares held by the foregoing funds. Jean Deleage, Alix Marduel & Farah Champsi (collectively known as the "Principals") are managing directors ("md") of ABPII & managers of AEBPII. As md & managers they may be deemed to share voting & investment powers over the share held by the funds. The principals disclaim beneficial ownership of all such shares held by the foregoing funds, except to the extent of their proportionate pecuniary interests therein. Stock beneficially owned by Alta BioPharma Partners II, L.P. Stock beneficially owned by Alta Embarcadero BioPharma Partners II, LLC Jean Deleage 2005-07-25 -----END PRIVACY-ENHANCED MESSAGE-----